SEC Form 4Coverage since Jun 12, 2026
$ANIX insider trading
Over the last 12 months, Anixa Biosciences insiders reported 10 buys totaling $200K and no sales across SEC Form 4 filings.
- Bought · 12m
- $200K 10 events
- Sold · 12m
- — 0 events
- Events · 12m
- 10 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $ANIX · 12Mvia TradingView
Top insiders · 12m
KUMAR AMITChief Executive Officer7× · $141K
Titterton Lewis H jr—3× · $58K
All insider trades
10 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 5,000 | $3.47 | $17K | +0.8% | — |
| Jul 27, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 5,000 | $3.44 | $17K | +0.8% | — |
| Jul 27, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 3,188 | $3.37 | $11K | +0.5% | — |
| Jul 24, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 3,000 | $3.73 | $11K | +0.5% | — |
| Jul 20, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 5,000 | $3.46 | $17K | +0.8% | — |
| Jul 20, 2026 | Titterton Lewis H jrD | ▲ Buy | 12,000 | $3.47 | $42K | +1.2% | — |
| Jul 15, 2026 | Titterton Lewis H jrD | ▲ Buy | 2,797 | $3.28 | $9K | +0.3% | — |
| Jul 10, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 5,000 | $3.04 | $15K | +0.8% | — |
| Jun 16, 2026 | Titterton Lewis H jrD | ▲ Buy | 2,836 | $2.64 | $7K | +0.3% | — |
| Jun 12, 2026 | KUMAR AMITChief Executive Officer · O·D | ▲ Buy | 21,000 | $2.5 | $53K | +3.4% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ANIX feed.